Substituted acetamide derivatives for treatment of hypocholesterolaemia, hyperlipaemia and arteriosclerosis
申请人:BANYU PHARMACEUTICAL CO., LTD.
公开号:EP0587430A1
公开(公告)日:1994-03-16
There are provided substituted acetamide derivatives represented by general formula (I):
wherein R¹, R², R³, R⁴, R⁵, R⁶, R⁷, R⁸, R⁹, R¹⁰, R¹¹, R¹², R¹³, n and Z are defined in the specification. The substituted acetamide derivatives strongly inhibit acylcoenzyme A cholesterol acyltransferase (ACAT) and are expected to be effective for the treatment and prevention of hypercholesterolemia, hyperlipemia and arteriosclerosis.
提供了通式 (I) 所代表的取代乙酰胺衍生物:
其中 R¹、R²、R³、R⁴、R⁵、R⁶、R⁷、R⁸、R⁹、R¹⁰、R¹¹、R¹²、R¹³、n 和 Z 在说明书中定义。取代的乙酰胺衍生物能强烈抑制酰辅酶 A 胆固醇酰基转移酶(ACAT),有望有效治疗和预防高胆固醇血症、高血脂症和动脉硬化。